StreetAlpha.app
Home › Stocks › LTRN

Lantern Pharma Inc. (LTRN)

$0.36
▼ −6.17%
LAST CLOSE · NOV 17

Lantern Pharma develops cancer drugs using an artificial intelligence platform to match them with suitable patients. It last closed at $0.36 on Nov 17, down 6.17% on the day. LTRN last reported earnings on Fri, Aug 14, 2026.

AI Auto Pilots
Is LTRN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
−$13.8M
EPS (diluted)
−$1.44
Valuation
Market cap
$5.8M
15.9M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$7.6M
At Sep 30
Shareholder equity
$1.4M
Shares outstanding
15.9M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$12.4M−$12.4MFY2021FY2022: −$14.3M−$14.3MFY2022FY2023: −$16.0M−$16.0MFY2023FY2024: −$20.8M−$20.8MFY2024FY2025: −$17.1M−$17.1MFY2025

From LTRN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 17). Last 12 months adds up the four latest quarters.

Last report
Aug 14
2026 · Before the open (BMO)
Reported EPS
-$0.28
vs -$0.38 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±39.9%
Priced in before that report
Analyst consensus
—
No ratings in 90 days
Loading…

Technical Analysis

LTRN · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 57% below its 20 day and 154% below its 50 day average. It is 528% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 23), oversold. The nearest support is the 52 week low at $0.36, and the nearest resistance the Pivot at $0.38.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 25.5%/day
Key levels
$4.3452 week high+1105.6%
$2.29200 day average+536.1%
$1.85100 day average+413.9%
$0.9350 day average+158.3%
$0.67Swing high (Nov 10)+86.1%
$0.5720 day average+58.3%
$0.39Pivot R1+8.3%
$0.38Pivot+5.6%
$0.3652 week low+0.0%
$0.36Last close
$0.35Pivot S1−2.8%
Indicators
RSI (14)23.46Oversold below 30Oversold
MACD-0.15Above its signal lineBullish
Stochastic1.4Near the bottom of its rangeOversold
ADX (14)48.4Strong downtrend
Williams %R-100.0Oversold below −80, overbought above −20Oversold
CCI (20)-160.8Oversold below −100, overbought above 100Oversold
Rate of change−39.4%Change over 10 sessionsBearish
ATR (14)$0.09Typical daily range, 25.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for LTRN

What happened before

See how LTRN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow LTRN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How LTRN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in LTRN in the last 90 days.

Loading…

See today’s whale options flow across the market →

LTRN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●16 buying vs 18 selling
  • ▲Held by funds +6.4 pts
  • ▲Funds holding +3
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4340+7.5%
In funds' top 1012−50.0%
Held by funds24.5%18.2%+6.4 pts
New / increased9 / 712 / 10−27.3%
Reduced / sold out12 / 68 / 7+20.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LTRN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LTRN is in one of them and how their past LTRN trades turned out.

LTRN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LTRN in an article yet. Here's the latest on the wider market.

About Lantern Pharma

Lantern Pharma is a Dallas, Texas company that develops cancer drugs. It uses an artificial intelligence platform, called RADR, to analyze large sets of medical and research data and to identify the patients most likely to respond to each drug. Its pipeline includes several small molecule candidates in clinical trials for solid tumors and blood cancers, and it also works on reviving older compounds that were previously halted. The company plans to offer some of its AI tools to other researchers and drug developers.

Headquarters
Dallas, TX